Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2Sarcoma 1Lymphoid 1Dermatologic 1CNS 1

Conditions

Osteosarcoma 2Rhabdomyosarcoma 1Neuroblastoma 1Neoplasms 1Melanoma 1Hodgkin Disease 1Hepatoblastoma 1Glioblastoma 1Fibrolamellar hepatocellular carcinoma 1Ependymoma 1Diffuse Intrinsic Pontine Glioma 1Carcinoma, Hepatocellular 1Brain Neoplasms 1

Interventions

Nivolumab 4Magnetic Resonance Spectroscopy 4fludarabine 3Fluorodeoxyglucose F18 3Cyclophosphamide 3Cisplatin 3ulixertinib 2sargramostim 2X-Rays 2Trastuzumab 2Sunitinib 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Oxaliplatin 2Melphalan 2Leucovorin 2FAPI-46 2Erlotinib Hydrochloride 2Cryosurgery 2Crizotinib 2Capecitabine 2Busulfan 2Bevacizumab 2trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sapanisertib 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × dostarlimab × CNS × Clear all
NCT06521567 2025-11-12

A Study of Cobolimab Plus Dostarlimab in Pediatric and Young Adult Participants With Cancer

GlaxoSmithKline

Phase 1/2 Active not recruiting
83 enrolled
CNSDermatologicGastrointestinalLymphoidSarcoma

Fibrolamellar hepatocellular carcinoma, Diffuse Intrinsic Pontine Glioma, Ependymoma, Glioblastoma, Carcinoma, Hepatocellular, Hodgkin Disease, Melanoma, Rhabdomyosarcoma, Osteosarcoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡